Judge Clears Purdue Pharma’s Restructuring Plan for Vote by Thousands of Claimants

The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.